Diamorphine 5mg and 10mg Injection: Accord have now confirmed that supplies are available. Stock should now be available again to order via the usual wholesalers Vaccines: For updates on other vaccine supply position, please refer to PHE’s Vaccine Update Bulletin found at the following address: Hepatitis B Vaccines Supplies of GSK vaccines have improved. MSD allocations remain set as they are. A mechanism remains in place for both suppliers to allow for exceptional orders if there is an urgent and immediate need. PHE previously developed temporary recommendations on hepatitis B vaccine including risk-based prioritisation of vaccine, dose-sparing and deferral of boosters Although, supply of Hepatitis B vaccines has improved, controlled stock management and ordering restrictions will continue to allow for the backlog of patients/staff who had vaccination deferred last year and because manufacturers have not got their usual full UK allocation A recovery plan for 2018 was published by PHE on 26th February 2018 and vaccine ordering was opened out in a phased approach over 2018 to lower priority group (4) patients, from March. Priority group 1-3 patients/staff will continue to have access to vaccine. Information on the temporary recommendations and recovery plan can be found at the following link: PHE have issued a letter to NHS and non-NHS occupational health service providers (see attached document) outlining the implication for OH Pneumococcal Polysaccharide Vaccine (PPV23): MSD are the sole UK supplier of this vaccine and are currently out of stock Further supplies are expected in mid-late September Supply may be intermittent throughout 2018 PHE have previously issued guidance to GP’s (see attached document) on how to manage patients if unable to obtain PPV vaccine. Updates on recommendations are available in February edition of PHE’s Vaccine Update Bulletin (Page 7) Menveo (meningitis A,C,W,Y): GSK are out of stock of Menveo until late 2018 (date has not yet been confirmed) Pfizer have confirmed they are in stock of Nimenrix and currently able to support increased demand Discontinuations Modecate (fluphenazine decanoate) injection As per previous notifications, Sanofi, the sole UK supplier of fluphenazine decanoate injection are discontinuing their product Modecate.
Diamorphine 5mg and 10mg Injection: Accord have now confirmed that supplies are available. Stock should now be available again to order via the usual wholesalers Vaccines: For updates on other vaccine supply position, please refer to PHE’s Vaccine Update Bulletin found at the following address: Hepatitis B Vaccines Supplies of GSK vaccines have improved. MSD allocations remain set as they are. A mechanism remains in place for both suppliers to allow for exceptional orders if there is an urgent and immediate need. PHE previously developed temporary recommendations on hepatitis B vaccine including risk-based prioritisation of vaccine, dose-sparing and deferral of boosters Although, supply of Hepatitis B vaccines has improved, controlled stock management and ordering restrictions will continue to allow for the backlog of patients/staff who had vaccination deferred last year and because manufacturers have not got their usual full UK allocation A recovery plan for 2018 was published by PHE on 26th February 2018 and vaccine ordering was opened out in a phased approach over 2018 to lower priority group (4) patients, from March. Priority group 1-3 patients/staff will continue to have access to vaccine. Information on the temporary recommendations and recovery plan can be found at the following link: PHE have issued a letter to NHS and non-NHS occupational health service providers (see attached document) outlining the implication for OH Pneumococcal Polysaccharide Vaccine (PPV23): MSD are the sole UK supplier of this vaccine and are currently out of stock Further supplies are expected in mid-late September Supply may be intermittent throughout 2018 PHE have previously issued guidance to GP’s (see attached document) on how to manage patients if unable to obtain PPV vaccine. Updates on recommendations are available in February edition of PHE’s Vaccine Update Bulletin (Page 7) Menveo (meningitis A,C,W,Y): GSK are out of stock of Menveo until late 2018 (date has not yet been confirmed) Pfizer have confirmed they are in stock of Nimenrix and currently able to support increased demand Discontinuations Modecate (fluphenazine decanoate) injection As per previous notifications, Sanofi, the sole UK supplier of fluphenazine decanoate injection are discontinuing their product Modecate.
Supply-issues-for-primary-care-Septmber-2018.docx